ClearSky Medical Diagnostics is thrilled to announce that two LID-Monitors, designed to help people with Parkinson’s control their condition, have been acquired at a hospital in Leeds.
Leeds Teaching Hospitals provides a comprehensive service for patients with Parkinson’s and other movement disorders, including specialised care, advice and support.
LID-Monitor can detect involuntary movements – a side effect, clinically known as dyskinesia, associated with Parkinson’s medication and allows home monitoring of patients over a 24-hour period.
It uses bespoke, biologically-inspired computer algorithms to produce an easy to interpret graph that clinicians can use to better prescribe timing and dosage of medication.
The accuracy of the data means clinical staff at Leeds have much more refined information with which to make decisions when adjusting medication.
The implementation follows intensive research at Leeds General Infirmary and other centres to help develop the equipment with ClearSky Medical Diagnostics.
A spokesman for Leeds Teaching Hospitals said: “The LID monitor was pioneered in Leeds and following that success the Leeds Teaching Hospitals Trust have purchased the Monitor for use in their very large Movement Disorders Service.”
Professor Stephen Smith, managing director at ClearSky Medical Diagnostics, says: “The LID-Monitor has the potential to reduce costs to hospitals and increase patients’ quality of life. We’re delighted to see two LID-Monitors implemented at Leeds Teaching Hospitals.”